Clin Mol Hepatol > Accepted Articles
Correspondence on Editorial regarding “Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Shunda Du1, Karin Wisskirchen2, Ke Zhang2, Ulrike Protzer3
1Department of Liver Surgery, Peking Union Medical College Hospital, PUMC, and Chinese Academy of Medical Sciences
2SCG Cell Therapy Pte. Ltd.
3Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Munich, Munich, Germany
Correspondence :  Shunda Du ,
Tel: 86-10-69152836, Fax: 86-10-69156043, Email: dushd@pumch.cn
Ulrike Protzer ,
Tel: 49-89-4140 6821, Fax: 49-89-4140 6823, Email: protzer@tum.de
Received: September 23, 2024  Revised: October 12, 2024   Accepted: October 20, 2024

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2766
TOTAL : 2228460
Close layer